Organic & Biomolecular Chemistry
Paper
24H), 0.92 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H); 13C NMR 18.7, 17.7; MS (ES+, MeOH): 553 ([M + Na]+, 100%); HRMS
(126 MHz, MeOD) δC 199.8, 178.2, 177.8, 177.7, 177.1, 175.3, (ES+, MeOH) m/z calcd for C23H42N6O6NaS [M + Na]+ 553.2784,
175.1, 173.7, 63.9, 61.3, 58.2, 58.0, 57.9, 57.8, 52.7, 52.2, 36.2, found 553.2775.
26.5, 26.4, 26.4, 24.9, 24.7, 24.6–24.2 (overlapping signals),
23.3, 18.6, 17.9, 17.7; MS (ES+, MeOH): 708 ([M + Na]+, 100%);
CbzValAib4Gly-ψ[CSNH]AibOMe 3
HRMS (ES+, MeOH) m/z calcd for C31H55N7O8NaS [M + Na]+
To a mixture of CbzValOH (31 mg, 0.12 mmol), HOAt (17 mg,
708.3725, found 708.3712.
0.12 mmol) and H-Aib4Gly-ψ[CSNH]AibOMe 14 (33 mg,
0.06 mmol) in dry CH2Cl2 (3 mL) was added EDC (0.022 mL,
0.12 mmol). The mixture was left stirring at room temperature
for 3 days, and then the solvent was evaporated. The residue
was taken up in EtOAc (5 mL) and washed with KHSO4 5%
(3 × 1 mL), sat. NaHCO3 (3 × 1 mL) and brine (1 mL). The
organic phase was dried (MgSO4) and the solvent removed
in vacuo. The crude product was purified by column chromato-
graphy (EtOAc–PE, 4 : 1) to give pure CbzValAib4Gly-ψ[CSNH]-
AibOMe (35 mg, 74%) as a white solid. Rf 0.65 (EtOAc–PE,
4 : 1); mp = 198–200 °C; [α]2D5 = −22.4; IR (ATR, cm−1): 3279,
2983, 1651, 1529, 1284, 1226, 1157; 1H NMR (500 MHz, MeOD)
δH 7.47–7.23 (m, 5H), 5.11 (s, 2H), 4.28 (d, J = 17.7 Hz, 1H),
4.14 (d, J = 17.6 Hz, 1H), 3.75 (d, J = 7.4 Hz, 1H), 3.63 (s, 3H),
2.08–1.97 (m, 1H), 1.67 (s, 6H), 1.52–1.32 (m, 24H), 1.02 (d, J =
7.0 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H; 13C NMR (126 MHz,
MeOD) δC 199.8, 177.7, 177.7, 177.7, 176.6, 175.3, 174.6, 159.0,
138.2, 129.6, 129.1, 128.7, 67.7, 62.8, 61.3, 58.1, 58.0, 57.7,
57.7, 52.7, 52.2, 31.2, 26.2, 26.2, 26.0, 25.9, 25.1–24.7 (over-
lapping signals), 24.5, 24.3, 19.6, 19.4, 19.3 ppm; MS (ES+,
MeOH): 786 ([M + Na]+, 100%); HRMS (ES+, MeOH) m/z calcd
for C36H57N7O9NaS [M + Na]+ 786.3831, found 786.3817.
N3Aib4Gly-ψ[CSNH]AibOMe 13
(1) Azlactone formation. N3Aib4OH (500 mg, 1.3 mmol) was
dissolved in dry CH2Cl2 (5 mL) and EDC (0.252 mL,
1.43 mmol) was added. The resulting solution was left stirring
for 3 h at room temperature. The solvent was evaporated in
vacuo and the residue was taken up in EtOAc (20 mL) and
washed with KHSO4 5% (3 × 5 mL). The organic phase was
dried (MgSO4) and concentrated to give the crude azlactone
product, which was used directly in the next step.
(2) Azlactone coupling. The crude azlactone was dissolved in
dry CH2Cl2 (5 mL) and HCl·H-Gly-ψ[CSNH]AibOMe 9 (230 mg,
1.01 mmol) was added, together with N,N-diisopropylethyl-
amine (0.232 mL, 1.33 mmol). The mixture was left stirring at
room temperature for 7 days, after which the solvent was
evaporated under reduced pressure. The residue was taken up
in EtOAc (10 mL) and washed with KHSO4 5% (3 × 2 mL), sat.
NaHCO3 (3 × 2 mL) and brine (2 mL). The organic phase was
dried (MgSO4) and the solvent removed in vacuo. The crude
product was purified by column chromatography (CH2Cl2–
MeOH, 97 : 3 → 95 : 5) to give pure N3Aib4Gly-ψ[CSNH]AibOMe
(250 mg, 44%) as a colourless solid. Rf 0.75 (CH2Cl2–MeOH,
95 : 5); mp = 190–192 °C (dec.); IR (ATR, cm−1): 3277, 2112,
1745, 1657, 1530, 1382, 1275, 1152; 1H NMR (500 MHz, CDCl3)
CbzPheAib4Gly-ψ[CSNH]AibOMe 4
δH 8.68 (s, 1H), 7.76 (t, J = 6.2 Hz, 1H), 7.36 (s, 1H), 6.93 To a mixture of CbzPheOH (37 mg, 0.12 mmol), HOAt (17 mg,
(s, 1H), 6.28 (s, 1H), 4.31 (d, J = 6.2 Hz, 2H), 3.64 (s, 3H), 1.67 0.12 mmol) and H-Aib4Gly-ψ[CSNH]AibOMe 14 (33 mg,
(s, 6H), 1.49 (s, 12H), 1.44 (s, 6H), 1.40 (s, 6H); 13C NMR 0.06 mmol) in dry CH2Cl2 (3 mL) was added EDC (0.022 mL,
(126 MHz, CDCl3) δC 198.6, 175.0, 174.2, 173.9, 173.7, 173.3, 0.12 mmol), followed by N,N-diisopropylethylamine (0.05 mL,
64.0, 60.3, 57.3, 57.0, 56.9, 52.4, 51.7, 25.5–25.4 (overlapping 0.03 mmol). The mixture was left stirring at room temperature
signals), 24.9, 24.4; MS (ES+, MeOH): 579 ([M + Na]+, 100%); for 3 days, and then the solvent was evaporated. The residue
HRMS (ES+, MeOH) m/z calcd for C23H40N8O6NaS [M + Na]+ was taken up in EtOAc (5 mL) and washed with KHSO4 5%
579.2689, found 579.2697.
(3 × 1 mL), sat. NaHCO3 (3 × 1 mL) and brine (1 mL). The
organic phase was dried (MgSO4) and the solvent removed
in vacuo. The crude product was purified by column chromato-
H-Aib4Gly-ψ[CSNH]AibOMe 14
N3Aib4Gly-ψ[CSNH]Aib-OMe 13 (112 mg, 0.2 mmol) was dis- graphy (CH2Cl2–MeOH, 95 : 5) to give pure CbzPheAib4-
solved in distilled THF (2 mL). Water (0.018 mL, 1 mmol) was Gly-ψ[CSNH]AibOMe (39 mg, 78%) as a white solid. Rf 0.5
added, followed by PMe3 (1 M solution in THF, 2 mL, (CH2Cl2–MeOH, 95 : 5); mp = 110–113 °C; [α]2D5 = −19.2; IR
2 mmol). The reaction mixture was stirred overnight at room (ATR, cm−1): 3291, 2984, 1657, 1529, 1383, 1226, 1155; 1H
temperature. The volatiles were removed under vacuum and NMR (500 MHz, MeOD) δH 7.90 (s, 1H), 7.81 (s, 2H), 7.39–7.16
the residue purified by column chromatography (CH2Cl2– (m, 1H), 5.10 (d, A of AB, J = 12.6 Hz, 1H), 5.06 (d, B of AB,
MeOH, 9 : 1 → 8 : 2) to give H-Aib4Gly-ψ[CSNH]AibOMe (85 mg, 12.6 Hz, 1H), 4.30 (d, A of AB, J = 17.7 Hz, 1H), 4.23 (t, J = 7.8
81%). Rf 0.10 (CH2Cl2–MeOH, 95 : 5); mp = 212–213 °C; Hz, 1H), 4.11 (d, B of AB, J = 17.7 Hz, 1H), 3.63 (s, 3H), 3.00
IR (ATR, cm−1): 3278, 1730, 1651, 1530, 1383, 1362, 1282, 1221, (ddd, J = 31.6, 13.6, 7.8 Hz, 2H), 1.67 (d, J = 2.5 Hz, 6H), 1.50
1
1155; H NMR (500 MHz, CDCl3) δH 8.73 (s, 1H), 8.22 (s, 1H), (s, 3H), 1.49 (s, 6H), 1.42 (s, 3H), 1.38 (s, 3H), 1.34 (s, 3H), 1.28
7.81 (t, J = 6.2 Hz, 1H), 7.69 (s, 1H), 6.36 (s, 1H), 4.31 (d, J = (s, 3H), 1.24 (s, 3H). 13C NMR (101 MHz, MeOD) δC 199.9,
6.2 Hz, 2H), 3.64 (s, 3H), 1.75 (brs, 2H), 1.68 (s, 6H), 1.50 177.9, 177.9, 177.8, 176.7, 175.5, 174.5, 158.7, 138.3, 138.2,
(s, 6H), 1.42 (s, 6H), 1.39 (s, 6H), 1.32 (s, 6H); 13C NMR 130.7, 129.7, 129.7, 129.2, 128.7, 128.1, 67.8, 61.4, 58.4, 58.3,
(75 MHz, CDCl3) δC 198.7, 175.4, 174.8, 174.4, 174.1, 174.1, 58.1, 57.9, 57.7, 52.8, 52.4, 38.4, 30.9, 26.6–26.3 (overlapping
60.4, 57.3, 56.7, 56.6, 55.5, 52.5, 51.8, 28.0, 25.5, 25.0, 24.4, signals), 25.1, 24.9, 24.8, 24.3, 24.1; MS (ES+, MeOH): 834
This journal is © The Royal Society of Chemistry 2014
Org. Biomol. Chem., 2014, 12, 836–843 | 841